Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Microarray Market
DNA Microarray Market size accounted for USD 3.4 billion in 2022 and is estimated to grow at 8.7% to reach USD 7.8 billion by 2032. The adoption of DNA microarrays has been experiencing remarkable growth across a multitude of scientific and medical applications.
Ongoing advancements in genomics have unveiled the complex genetic foundations of various diseases, spurring the need for high-throughput tools such as DNA microarrays to comprehensively analyse gene expression and genomic alterations. Also, DNA microarrays have become crucial in biomedical research, empowering scientists to simultaneously investigate thousands of genes, facilitating groundbreaking discoveries in disease mechanisms, drug responses, and the identification of crucial biomarkers. Such associated advantages is expected to supplement market size.
A DNA microarray, also known as a DNA chip or gene chip, is a powerful laboratory tool used in molecular biology and genomics to analyse the expression levels of thousands of genes simultaneously. It allows researchers to study how genes are turned on or off in a cell or tissue sample, providing valuable insights into gene regulation, function, and their roles in various biological processes.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
DNA Microarray Market Size in 2022: | USD 3.4 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.7% |
2032 Value Projection: | USD 7.8 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 264 |
Segments covered: | Product, Type, Application, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|